Diane L. Cookfair

Jacobs Institute — United States

Medicine · Health Sciences

28h-index7.3kcitations50works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(29), Systemic Lupus Erythematosus Research(10), Peripheral Neuropathies and Disorders(10), Polyomavirus and related diseases(5), Endometrial and Cervical Cancer Treatments(4)

Publications50 total

Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium
Multiple Sclerosis Journal·2018· 43 citedOpen Access
Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk
Journal of the Neurological Sciences·2016· 28 cited
Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)
BMC Neurology·2016· 16 citedOpen Access
Disclosure of disease status among employed multiple sclerosis patients: Association with negative work events and accommodations
Multiple Sclerosis Journal·2014· 48 cited
Cancer Mortality Following Radiotherapy for Benign Gynecologic Disorders
Radiation Research·2012· 15 cited
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study
Journal of Neurology·2012· 40 cited
Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients
Journal of Neurology Neurosurgery & Psychiatry·2010· 88 cited
Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients
Journal of the International Neuropsychological Society·2010· 149 cited
Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis. A case–control diffusion imaging study
Pathophysiology·2010· 11 citedOpen Access
Validity of the California Verbal Learning Test–II in Multiple Sclerosis
The Clinical Neuropsychologist·2009· 100 cited
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
Journal of Neurology Neurosurgery & Psychiatry·2007· 82 cited
I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy
Multiple Sclerosis Journal·2007· 75 cited
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
Journal of the International Neuropsychological Society·2006· 780 cited
Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS
NeuroImage·2005· 61 cited
In brief
Current Problems in Surgery·2003
Interferons in relapsing remitting multiple sclerosis
The Lancet·2003· 8 citedOpen Access
Predictive immunophenotypes: Disease‐related profile in chronic fatigue syndrome
Cytometry Part B Clinical Cytometry·2003· 19 citedOpen Access
Multiple Sclerosis: Experience with Large Clinical Trials
2001
Neuropsychological effects of interferon β‐1a in relapsing multiple sclerosis
Annals of Neurology·2000· 164 cited
Neuropsychological effects of interferon ?-1a in relapsing multiple sclerosis
Annals of Neurology·2000· 292 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Bianca Weinstock‐Guttman(14), Donald E. Goodkin(11), Jack H. Simon(11), Robert M. Herndon(10), Andres Μ. Salazar(10), Jill S. Fischer(10), Karl Wende(9), Richard A. Rudick(8), Dennis Bourdette(8), J R Richert(7), Nancy A. Simonian(7), Robert Zivadinov(7), Lawrence Jacobs(6), Carol M. Brownscheidle(6), Michael E. Coats(6), Barbara Scherokman(6), Ruth H. Whitham(6), Ralph H. B. Benedict(6), R. A. Rudick(6), John R. Richert(5)